Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder

Psychoneuroendocrinology

Volumn 31, Issue 3, 2006, Pages 355-360

  Denys, Damiaan ^a   Fluitman, Sjoerd ^a   Kavelaars, Annemieke ^a   Heijnen, Cobi ^a   Westenberg, Herman G M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cytokines; Immune system; Obsessive compulsive disorder; Paroxetine; TNF ; Venlafaxine

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; PAROXETINE; TUMOR NECROSIS FACTOR ALPHA; VENLAFAXINE;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EX VIVO STUDY; FEMALE; HUMAN; IMMUNE SYSTEM; MALE; MONOCYTE; NATURAL KILLER CELL; OBSESSIVE COMPULSIVE DISORDER; OUTPATIENT; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME;

ADULT; CYCLOHEXANOLS; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 32944460943     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2005.08.016     Document Type: Article

References (33)

1. F. Brambilla, G. Perna, L. Bellodi, C. Arancio, A. Bertani, G. Perini, C. Carraro, and F. Gava Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders Biol. Psychiatry 42 1997 976 981
2. I. Cloez-Tayarani, A.F. Petit-Bertron, H.D. Venters, and J.M. Cavaillon Differential effect of serotonin on cytokine production in lipopolysaccharide- stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine(2A) receptors Int. Immunol. 15 2003 233 240
3. D. Denys, S. Fluitman, A. Kavelaars, C. Heijnen, and H. Westenberg Decreased TNF-alpha and NK activity in obsessive-compulsive disorder Psychoneuroendocrinology 29 2004 945 952
4. D. Denys, H.J. van Megen, W.N. van der, and H.G. Westenberg A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder J. Clin. Psychiatry 65 2004 37 43
5. M.G. Frank, S.E. Hendricks, D.R. Johnson, J.L. Wieseler, and W.J. Burke Antidepressants augment natural killer cell activity: in vivo and in vitro Neuropsychobiology 39 1999 18 24
6. W.K. Goodman, L.H. Price, S.A. Rasmussen, C. Mazure, P. Delgado, G.R. Heninger, and D.S. Charney The Yale-Brown Obsessive Compulsive Scale. II. Validity Arch. Gen. Psychiatry 46 1989 1012 1016
7. W.K. Goodman, L.H. Price, S.A. Rasmussen, C. Mazure, R.L. Fleischmann, C.L. Hill, G.R. Heninger, and D.S. Charney The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability Arch. Gen. Psychiatry 46 1989 1006 1011
8. M. Hamilton The assessment of anxiety states by rating Br. J. Med. Psychol. 32 1959 50 55
9. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
10. K. Hellstrand, and S. Hermodsson Enhancement of human natural killer cell cytotoxicity by serotonin: role of non-T/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors Cell Immunol. 127 1990 199 214
11. D. Hinze-Selch, A. Schuld, T. Kraus, M. Kuhn, M. Uhr, M. Haack, and T. Pollmacher Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine Neuropsychopharmacology 23 2000 13 19
12. A. Kagaya, A. Kugaya, M. Takebayashi, M. Fukue-Saeki, T. Saeki, S. Yamawaki, and Y. Uchitomi Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan Neuropsychobiology 43 2001 59 62
13. G. Kenis, and M. Maes Effects of antidepressants on the production of cytokines Int. J. Neuropsychopharmacol. 5 2002 401 412
14. T. Kraus, M. Haack, A. Schuld, D. Hinze-Selch, D. Koethe, and T. Pollmacher Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine Pharmacopsychiatry 35 2002 220 225
15. M. Kubera, V. Holan, R. Mathison, and M. Maes The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice Psychoneuroendocrinology 25 2000 785 797
16. M. Kubera, A. Simbirtsev, R. Mathison, and M. Maes Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice Psychiatry Res. 96 2000 255 266
17. M. Kubera, A.H. Lin, G. Kenis, E. Bosmans, D. van Bockstaele, and M. Maes Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio J. Clin. Psychopharmacol. 21 2001 199 206
18. M. Kubera, G. Kenis, E. Bosmans, M. Kajta, A. Basta-Kaim, S. Scharpe, B. Budziszewska, and M. Maes Stimulatory effect of antidepressants on the production of IL-6 Int. Immunopharmacol. 4 2004 185 192
19. K. Lang, T.L. Drell, B. Niggemann, K.S. Zanker, and F. Entschladen Neurotransmitters regulate the migration and cytotoxicity in natural killer cells Immunol. Lett. 90 2003 165 172
20. M. Maes Major depression and activation of the inflammatory response system Adv. Exp. Med. Biol. 461 25-46 1999 25 46
21. M. Maes, G. Kenis, M. Kubera, M. De Baets, H. Steinbusch, and E. Bosmans The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway Int. Immunopharmacol. 5 2005 609 618
22. O. Mikova, R. Yakimova, E. Bosmans, G. Kenis, and M. Maes Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis Eur. Neuropsychopharmacol. 11 2001 203 208
23. P. Monteleone, F. Catapano, M. Fabrazzo, A. Tortorella, and M. Maj Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder Neuropsychobiology 37 1998 182 185
24. P.J. Neveu, and N. Castanon Is there evidence for an effect of antidepressant drugs on immune function? Adv. Exp. Med. Biol. 461 267-81 1999 267 281
25. B.A. Nic Dhonnchadha, N. Ripoll, F. Clenet, M. Hascoet, and M. Bourin Implication of 5-HT(2) receptor subtypes in the mechanism of action of antidepressants in the four plates test Psychopharmacology (Berl) 2004 264 271
26. A.V. Ravindran, J. Griffiths, Z. Merali, and H. Anisman Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls J. Affect. Disord. 52 1999 1 10
27. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller, T. Hergueta, R. Baker, and G.C. Dunbar The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J. Clin. Psychiatry 59 Suppl. 20 1998 22 33
28. Y. Shen, T.J. Connor, Y. Nolan, J.P. Kelly, and B.E. Leonard Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat Life Sci. 65 1999 1773 1786
29. A. Sluzewska, J.K. Rybakowski, M. Laciak, A. Mackiewicz, M. Sobieska, and K. Wiktorowicz Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine Ann. N.Y. Acad. Sci. 762 1995 474 476
30. C. Song The interactions between cytokines and neurotransmitters in depression and stress: possible mechnism of antidepressant treatments Hum. Psychopharmacol. Clin. Exp 15 2000 199 211
31. S.E. Swedo, H.L. Leonard, M. Garvey, B. Mittleman, A.J. Allen, S. Perlmutter, L. Lougee, S. Dow, J. Zamkoff, and B.K. Dubbert Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases Am. J. Psychiatry 155 1998 264 271
32. C. Tuglu, S.H. Kara, O. Caliyurt, E. Vardar, and E. Abay Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder Psychopharmacology (Berl) 2003 264 271
33. R. Weizman, N. Laor, Y. Barber, H. Hermesh, I. Notti, M. Djaldetti, and H. Bessler Cytokine production in obsessive-compulsive disorder Biol. Psychiatry 40 1996 908 912